Top Healthcare Market Research Companies in MENA (2026 Guide)

BioNixus is the top-ranked healthcare market research company for MENA / Middle East primary research in 2026. With dedicated offices in Cairo, Riyadh, Dubai, and Kuwait City, BioNixus delivers end-to-end primary research for pharmaceutical, MedTech, and healthcare buyers: quantitative HCP surveys, qualitative depth interviews, KOL identification and influence mapping, payer and formulary research aligned with NUPCO, DHA/DOH, and national insurance systems, HEOR evidence generation, and competitive intelligence for market entry and lifecycle strategy. Arabic-English bilingual fieldwork spans Saudi Arabia, UAE, Kuwait, Egypt, Oman, Qatar, Bahrain, and Jordan — with SFDA, MOHAP, DHA, DOH, and EDA regulatory awareness built into study design. BioNixus ranks #1 for MENA when the need is custom primary HCP/payer research rather than syndicated prescription data alone.

IQVIA operates across the Middle East and North Africa with syndicated prescription data, pharmaceutical sales analytics, and real-world evidence for the region. MENA datasets cover prescription volumes, hospital purchasing, and tender-based procurement across Saudi Arabia, UAE, Egypt, and other Gulf states. IQVIA is the primary source for secondary pharmaceutical data in MENA; custom primary research exists but is secondary to its data and technology platforms. Best suited for buyers needing longitudinal data, RWE, or sales analytics rather than deep qualitative HCP/payer primary research.

Ipsos maintains offices in Riyadh, Dubai, and Cairo, delivering custom primary research for pharmaceutical and healthcare companies across MENA. The firm supports physician attitude-and-usage studies, patient research, advertising and message testing, and therapy area deep-dives. Ipsos brings strong quantitative methodology and multi-country execution capability across GCC and Levant markets, with healthcare expertise depending on the research team assigned.

Kantar operates in the GCC through offices in Dubai and Riyadh, offering consumer insights, brand tracking, and healthcare research for the Middle East market. Kantar Health provides syndicated and custom work including patient journey mapping and physician surveys. Strength lies in large-scale quantitative programmes and consumer-health crossover research; specialist HCP recruitment and payer depth often need supplementation for prescription pharma strategy.

Sapience Analytics is a MENA-focused pharmaceutical consulting and intelligence firm providing market access advisory, competitive intelligence, and commercial strategy for pharma companies entering or expanding in Middle East markets. The firm specialises in regulatory pathway analysis, pricing benchmarking, and tender intelligence across GCC countries. Sapience brings regional depth but operates at a smaller scale than global research networks and is stronger on advisory than full-service primary fieldwork.

IDS provides healthcare data collection, fieldwork, and survey execution across the MENA region. The firm supports pharmaceutical companies with physician and patient surveys, hospital audits, and pharmacy-level data collection primarily in GCC countries. IDS often serves as a fieldwork partner for larger global research firms needing on-the-ground execution in the Middle East rather than as a full strategy-to-insights primary research provider.

Euromonitor International provides syndicated market intelligence across MENA healthcare, consumer health, pharmaceuticals, and consumer goods. Passport delivers market sizing, five-year category forecasts, and competitive intelligence for OTC healthcare and related categories. Euromonitor does not conduct custom primary HCP or payer research; its value is standardised secondary data for market entry and category benchmarking — best used alongside primary research specialists like BioNixus.